Vertex to Report Fourth Quarter and Full Year 2012 Financial Results on Tuesday, January 29
CAMBRIDGE, Mass.--(BUSINESS WIRE)--
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its
fourth quarter and full year 2012 financial results on Tuesday, January
29, 2013 after the financial markets close. The company will host a
conference call at 5:00 p.m. ET.
The conference call will be webcast live and a link to the webcast may
be accessed from the "Vertex Events" page of Vertex's website at www.vrtx.com.
A replay of the conference call and webcast will be archived on the
company's website until February 5, 2013. To ensure a timely connection,
it is recommended that users register at least 15 minutes prior to the
Vertex creates new possibilities in medicine. Our team discovers,
develops and commercializes innovative therapies so people with serious
diseases can lead better lives.
Vertex scientists and our collaborators are working on new medicines to
cure or significantly advance the treatment of hepatitis C, cystic
fibrosis, rheumatoid arthritis and other life-threatening diseases.
Founded more than 20 years ago in Cambridge, Mass., we now have ongoing
worldwide research programs and sites in the U.S., U.K. and Canada.
Today, Vertex has more than 2,000 employees around the world, and for
three years in a row, Science magazine has named Vertex one of
its Top Employers in the life sciences. Vertex's press releases are
available at www.vrtx.com.
Vertex Pharmaceuticals Incorporated
Kate Carlson, 617-341-6668
Source: Vertex Pharmaceuticals Incorporated
News Provided by Acquire Media
Close window | Back to top